Amend 004 - Anthrasil vaccine - EMERGENT BIOSOLUTIONS CANADA INC.

Status Awarded

Contract number 6D024-203933/001/PH

Solicitation number 6D024-203933/A

Publication date

Contract award date

Last amendment date

Amendment value

CAD 10,280,424.00
Description

This contract was awarded to:

Emergent BioSolutions Canada Inc.
Anthrasil vaccine - EMERGENT BIOSOLUTIONS CANADA INC.
Business address
155 Innovation Dr
Winnipeg, Manitoba, R3T 5Y3
CA
Notice type
Directed Contract
Language(s)
English
,
French
Selection criteria
Not applicable
Region(s) of delivery
National Capital Region (NCR)

View the full contract history for Emergent BioSolutions Canada Inc..

Contract duration

The contract will be for a period of 32 month(s), from 2021/07/20 to 2024/03/31.

Total value of contract

This is the total value of this contract, which includes the initial contract value and the sum of all amendments.

CAD 37,290,844.80

Commodity - UNSPSC

  • 51000000 - Drugs and Pharmaceutical Products

Trade agreements

  • Canadian Free Trade Agreement (CFTA)

Reason for limited tendering

A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:

  • Exclusive Rights
Contact information

Contracting organization

Organization
Department of Public Works and Government Services (PSPC)
Address
11 Laurier St, Phase III, Place du Portage
Gatineau, Quebec, K1A 0S5
Canada
Contracting authority
Joy, Sharon (SPAC/PSPC)
Email
sharon.joy@tpsgc-pwgsc.gc.ca

Buying organization(s)

Organization
Public Health Agency of Canada (PHAC)
Address
130 Colonnade Road
Ottawa, Ontario, K1A 0K9
Canada
Date modified: